Construction of Recombinant Attenuated Salmonella enterica Serovar Typhimurium Vaccine Vector Strains for Safety in Newborn and Infant Mice
Open Access
- 1 March 2010
- journal article
- research article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 17 (3), 354-362
- https://doi.org/10.1128/cvi.00412-09
Abstract
Recombinant bacterial vaccines must be safe, efficacious, and well tolerated, especially when administered to newborns and infants to prevent diseases of early childhood. Many means of attenuation have been shown to render vaccine strains susceptible to host defenses or unable to colonize lymphoid tissue effectively, thus decreasing their immunogenicity. We have constructed recombinant attenuated Salmonella vaccine strains that display high levels of attenuation while retaining the ability to induce high levels of immunogenicity and are well tolerated in high doses when administered to infant mice as young as 24 h old. The strains contain three means of regulated delayed attenuation, as well as a constellation of additional mutations that aid in enhancing safety, regulate antigen expression, and reduce disease symptoms commonly associated with Salmonella infection. The vaccine strains are well tolerated when orally administered to infant mice 24 h old at doses as high as 3.5 × 10 8 CFU.Keywords
This publication has 58 references indexed in Scilit:
- Immunogenicity of a Live RecombinantSalmonellaentericaSerovar Typhimurium Vaccine ExpressingpspAin Neonates and Infant Mice Born from Naïve and Immunized MothersClinical and Vaccine Immunology, 2010
- Salmonella entericaSerovar Typhimurium Strains with Regulated Delayed Attenuation In VivoInfection and Immunity, 2009
- Evaluation of new generationSalmonella entericaserovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspAProceedings of the National Academy of Sciences of the United States of America, 2009
- Regulated programmed lysis of recombinant Salmonella in host tissues to release protective antigens and confer biological containmentProceedings of the National Academy of Sciences of the United States of America, 2008
- Analysis of Type II Secretion of Recombinant Pneumococcal PspA and PspC in a Salmonella enterica Serovar Typhimurium Vaccine with Regulated Delayed Antigen SynthesisInfection and Immunity, 2008
- Presence of Wild-Type and Attenuated Salmonella enterica Strains in Brain Tissues following Inoculation of Mice by Different RoutesInfection and Immunity, 2008
- Nonrecombinant and recombinant avirulent Salmonella vaccines for poultryVeterinary Immunology and Immunopathology, 1996
- A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide.JCI Insight, 1996
- Aberrant Migration of Lipopolysaccharide in Sodium Dodecyl Sulfate/Poyacrylamide Gel ElectrophoresisJBIC Journal of Biological Inorganic Chemistry, 1983
- L‐arabinose transport and the L‐arabinose binding protein of escherichia coliJournal of Supramolecular Structure, 1977